Lumera Corporation's Dinu to Speak at the Lux Executive Summit
Lumera zu myNews hinzufügen Was ist das?
Lumera Corporation (NASDAQ:LMRA), a leader in the emerging field of
nanotechnology, today announced that Dr. Raluca Dinu, Vice President –
Electro-Optic Business Unit, will present an overview of Lumera at the
Lux Executive Summit being held in Boston on October 15.
The Lux Executive Summit brings together corporations, startups, and
academic researchers working on commercializing cutting-edge
technologies in fields including nanotech and cleantech. For more
information on the conference, visit www.luxexecutivesummit.com/Overview/Overview.php.
About Lumera
Lumera is a leader in the emerging field of nanotechnology. The company
designs proprietary molecular structures and polymer compounds for the
communications/computing industries and for the bioscience industry
through its wholly-owned subsidiary, Plexera Bioscience LLC. Both of
these represent large market opportunities. The company also has
developed proprietary processes for fabricating such devices. For more
information, please visit www.lumera.com.
Certain statements contained in this release are forward-looking
statements that involve a number of risks and uncertainties. Factors
that could cause actual results to differ materially from those
projected in the company's forward-looking statements include the
following: market acceptance of our technologies and products; our
ability to obtain financing; our financial and technical resources
relative to those of our competitors; our ability to keep up with rapid
technological change; government regulation of our technologies; our
ability to enforce our intellectual property rights and protect our
proprietary technologies; the ability to obtain additional contract
awards and to develop partnership opportunities; the timing of
commercial product launches; the ability to achieve key technical
milestones in key products; and other risk factors identified from time
to time in the company's SEC reports, including its Annual Report on
Form 10-K, and its Quarterly Reports on Form 10-Q.
